Tech Company Financing Transactions
Cytrellis Biosystems Funding Round
Cytrellis Biosystems secured a financing round on 4/29/2016. Backers included Merz Pharma.
Transaction Overview
Company Name
Announced On
4/29/2016
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Merz Pharma (Hans-Jörg Bergler)
Proceeds Purpose
Proceeds purposes were not disclosed by the company.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
299C Washington St.
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Website
Email Address
Overview
Cytrellis Biosystems, Inc. is a clinical stage medical technology company developing a new, proprietary class of aesthetic devices.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Karen Cronholm
Chief Financial Officer
Diane Marcou
VP - Marketing
Cathleen Alaimo
VP - R & D
Steve Gemmell
VP - Sales
Michael Williams
Browse more venture capital transactions:
Prev: 4/29/2016: VividCortex venture capital transaction
Next: 4/29/2016: NeuMoDx Molecular venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. All VC database entries reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs